Skip to main content

Table 3 Total cholesterol, triglycerides, LDL, HDL concentrations (mg/dL), total cholesterol: LDL, total cholesterol: HDL and LDL: HDL ratios of groups 1 and 2

From: Anti-hyperglycaemic effects of herbal porridge made of Scoparia dulcis leaf extract in diabetics – a randomized crossover clinical trial

 

Study period 1

Study period 2

TC (mg/dL)

Test (mean ± SEM)

Control (mean ± SEM)

 

0 week

12 weeks

14 weeks

26 weeks

Group 1a

228 ± 12

235 ± 13

246 ± 10

224 ± 10

 

Control (mean ± SEM)

Test (mean ± SEM)

 

0 week

12 weeks

14 weeks

26 weeks

Group 2b

211 ± 14

233 ± 10

224 ± 14

232 ± 11

TG (mg/dL)

Test (mean ± SEM)

Control (mean ± SEM)

Group 1a

0 week

12 weeks

14 weeks

26 weeks

123 ± 9

139 ± 15

182 ± 20

175 ± 23

Control (mean ± SEM)

Test (mean ± SEM)

Group 2b

0 week

12 weeks

14 weeks

26 weeks

142 ± 15

185 ± 15

171 ± 16

164 ± 19

LDL (mg/dL)

Test (mean ± SEM)

Control (mean ± SEM)

Group 1a

0 week

12 weeks

14 weeks

26 weeks

163 ± 11

168 ± 11

169 ± 10

151 ± 8

Control (mean ± SEM)

Test (mean ± SEM)

Group 2b

0 week

12 weeks

14 weeks

26 weeks

137 ± 14

152 ± 9

147 ± 11

153 ± 10

HDL (mg/dL)

Test (mean ± SEM)

Control (mean ± SEM)

Group 1a

0 week

12 weeks

14 weeks

26 weeks

39.5 ± 2.1

39.0 ± 1.8

40.3 ± 1.9

37.3 ± 2.0

Control (mean ± SEM)

Test (mean ± SEM)

Group 2b

0 week

12 weeks

14 weeks

26 weeks

43.9 ± 2.8

42.5 ± 2.1

42.8 ± 2.8

44.8 ± 2.3

 

Study Period 1

Study Period 2

TC:LDL

Test (mean ± SEM)

Control (mean ± SEM)

 

0 week

12 weeks

14 weeks

26 weeks

Group 1a

1.43 ± 0.04

1.49 ± 0.05

1.42 ± 0.03

1.47 ± 0.03

 

Control (mean ± SEM)

Test (mean ± SEM)

 

0 week

12 weeks

14 weeks

26 weeks

Group 2b

1.63 ± 0.06

1.56 ± 0.03

1.56 ± 0.05

1.55 ± 0.04

TC:HDL

Test (mean ± SEM)

Control (mean ± SEM)

 

0 week

12 weeks

14 weeks

26 weeks

Group 1a

6.28 ± 0.40

5.69 ± 0.50

3.95 ± 0.28

4.20 ± 0.32

 

Control (mean ± SEM)

Test (mean ± SEM)

 

0 week

12 weeks

14 weeks

26 weeks

Group 2b

5.22 ± 0.54

5.62 ± 0.34

5.50 ± 0.38

5.53 ± 0.43

LDL:HDL

Test (mean ± SEM)

Control (mean ± SEM)

 

0 week

12 weeks

14 weeks

26 weeks

Group 1a

4.33 ± 0.35

4.28 ± 0.28

6.29 ± 0.39

5.89 ± 0.37

 

Control (mean ± SEM)

Test (mean ± SEM)

 

0 week

12 weeks

14 weeks

26 weeks

Group 2b

3.38 ± 0.48

3.69 ± 0.28

3.62 ± 0.32

3.71 ± 0.36

AI

Test (mean ± SEM)

Control (mean ± SEM)

 

0 week

12 weeks

14 weeks

16 weeks

Group 1a

0.49 ± 0.05

0.54 ± 0.06

0.61 ± 0.06

0.64 ± 0.7

 

Control (mean ± SEM)

Test (mean ± SEM)

 

0 week

12 weeks

14 weeks

16 weeks

Group 2b

0.50 ± 0.06

0.62 ± 0.04

0.59 ± 0.05

0.54 ± 0.06

  1. Week 0 and week 14 indicates the basal serum parameters as those values have been obtained prior to the intervention
  2. an = 16, bn = 19; SEM = standard error of mean; Superscripts indicate a significant difference in a parameter when compared to basal value within a study period (p < 0.05)